Abstract
The characteristics of three combinations of thiopentone and etomidate [in the ratios of thiopentone (mg):etomidate (mg) of 5:1, 13:1 and 25:1] have been compared with the individual agents alone for the induction of anaesthesia. The incidence of pain on injection and abnormal movements was less with the combination containing the highest ratio of thiopentone to etomidate, when compared to etomidate alone. The mixtures did not otherwise confer any advantages over the individual agents.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cundy J. M., Scott W. E. Sequential use of thiopentone and etomidate in anaesthesia for termination of pregnancy. Anaesthesia. 1983 Feb;38(2):155–158. doi: 10.1111/j.1365-2044.1983.tb13938.x. [DOI] [PubMed] [Google Scholar]
- Lowe S. S. The prevention of etomidate-induced myoclonus. Anaesthesia. 1984 Jan;39(1):70–71. doi: 10.1111/j.1365-2044.1984.tb09471.x. [DOI] [PubMed] [Google Scholar]
- Morgan M., Lumley J., Whitwam J. G. Etomidate, a new water-soluble non-barbiturate intravenous induction agent. Lancet. 1975 Apr 26;1(7913):955–956. doi: 10.1016/s0140-6736(75)92011-5. [DOI] [PubMed] [Google Scholar]
- Watkins J. Etomidate: an 'immunologically safe' anaesthetic agent. Anaesthesia. 1983 Jul;38 (Suppl):34–38. doi: 10.1111/j.1365-2044.1983.tb15174.x. [DOI] [PubMed] [Google Scholar]
- Yelavich P. M., Holmes C. M. Etomidate: a foreshortened clinical trial. Anaesth Intensive Care. 1980 Nov;8(4):479–483. doi: 10.1177/0310057X8000800417. [DOI] [PubMed] [Google Scholar]